Claude Gravel, Ph.D.
Director, Gene transfer laboratory
Development of immunological tools for the study and treatment of the brain
Professor Claude Gravel is Director of the Gene Transfer laboratory. He works to combine the tools of gene therapy with those of immunology to develop new therapeutic approaches for the treatment of devastating degenerative diseases such as amyotrophic lateral sclerosis. He has been a pioneer in the use of viral vectors for the treatment of inherited retinal degeneration and motor neuron degeneration in animal models.
Professor Claude Gravel was one of the founding members of the Neurophotonics Center, and is the founder of the Center's Molecular Tools Platform, which is essential to the research of several researchers at the Research Center.
Gene Therapy, Gene Transfer, Viral Vectors, Neurotrophic Factors, Retina, Motor Neurons, Apoptosis Retinitis, Amyotrophic Lateral, Sclerosis, single-chain-antibodies
2601, chemin de la Canardière
Québec (Québec) G1J 2G3